- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical Trial Design in Juvenile Idiopathic Arthritis
Authors
Keywords
-
Journal
PEDIATRIC DRUGS
Volume 19, Issue 5, Pages 379-389
Publisher
Springer Nature
Online
2017-06-13
DOI
10.1007/s40272-017-0244-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical trials for authorized biosimilars in the European Union: a systematic review
- (2016) Johanna Mielke et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Biosimilars in rheumatic diseases: structural and functional variability that may impact clinical and regulatory decisions
- (2016) Amit Lakhanpal et al. CLINICAL RHEUMATOLOGY
- Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: a randomised trial
- (2016) Nicolino Ruperto et al. LANCET
- Moving toward personalized medicine in rheumatoid arthritis: SNPs in methotrexate intracellular pathways are associated with methotrexate therapeutic outcome
- (2016) Aurea Lima et al. PHARMACOGENOMICS
- Stratification, Hypothesis Testing, and Clinical Trial Simulation in Pediatric Drug Development
- (2016) Ann W. McMahon et al. Therapeutic Innovation & Regulatory Science
- Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline forUGT1A1and Atazanavir Prescribing
- (2015) RS Gammal et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines forCYP3A5Genotype and Tacrolimus Dosing
- (2015) KA Birdwell et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for human leukocyte antigen B (HLA-B) genotype and allopurinol dosing: 2015 update
- (2015) Y Saito et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline forCYP2D6andCYP2C19Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors
- (2015) JK Hicks et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Use of Biosimilars in Paediatric Inflammatory Bowel Disease
- (2015) Lissy de Ridder et al. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
- Pharmacologic studies in vulnerable populations: Using the pediatric experience
- (2015) Kanecia Zimmerman et al. SEMINARS IN PERINATOLOGY
- Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial
- (2014) Hermine I Brunner et al. ANNALS OF THE RHEUMATIC DISEASES
- Adaptive Clinical Trial Design
- (2014) Shein-Chung Chow Annual Review of Medicine
- Off-Label Use of Drugs in Children
- (2014) et al. PEDIATRICS
- A148: A Multi-Center, Double-Blind, Randomized-Withdrawal Trial of Subcutaneous Golimumab in Pediatric Patients With Active Polyarticular Course Juvenile Idiopathic Arthritis Despite Methotrexate Therapy: Week 48 Results
- (2014) Hermine Brunner et al. Arthritis & Rheumatology
- Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy and Safety of Rilonacept in the Treatment of Systemic Juvenile Idiopathic Arthritis
- (2014) Norman T. Ilowite et al. Arthritis & Rheumatology
- A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis: the PLANETRA study
- (2013) Dae Hyun Yoo et al. ANNALS OF THE RHEUMATIC DISEASES
- A randomised, double-blind, multicentre, parallel-group, prospective study comparing the pharmacokinetics, safety, and efficacy of CT-P13 and innovator infliximab in patients with ankylosing spondylitis: the PLANETAS study
- (2013) Won Park et al. ANNALS OF THE RHEUMATIC DISEASES
- Clinical Pharmacogenetics Implementation Consortium Guidelines for Thiopurine Methyltransferase Genotype and Thiopurine Dosing: 2013 Update
- (2013) M V Relling et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 Update
- (2013) S A Scott et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Advances from clinical trials in juvenile idiopathic arthritis
- (2013) Daniel J. Lovell et al. Nature Reviews Rheumatology
- Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans for New-Onset Polyarticular Juvenile Idiopathic Arthritis
- (2013) Sarah Ringold et al. ARTHRITIS CARE & RESEARCH
- Intravenous golimumab is effective in patients with active rheumatoid arthritis despite methotrexate therapy with responses as early as week 2: results of the phase 3, randomised, multicentre, double-blind, placebo-controlled GO-FURTHER trial
- (2012) Michael E Weinblatt et al. ANNALS OF THE RHEUMATIC DISEASES
- The State of the Art in the Development of Biosimilars
- (2012) Mark McCamish et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Pharmacogenomics in pediatric rheumatology
- (2012) Mara L. Becker CURRENT OPINION IN RHEUMATOLOGY
- Two Randomized Trials of Canakinumab in Systemic Juvenile Idiopathic Arthritis
- (2012) Nicolino Ruperto et al. NEW ENGLAND JOURNAL OF MEDICINE
- Randomized Trial of Tocilizumab in Systemic Juvenile Idiopathic Arthritis
- (2012) Fabrizio De Benedetti et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pharmacogenetics, Pharmacogenomics, and Individualized Medicine
- (2011) Q. Ma et al. PHARMACOLOGICAL REVIEWS
- Innovative clinical trial design for pediatric therapeutics
- (2011) Matthew M Laughon et al. Expert Review of Clinical Pharmacology
- A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)
- (2010) P. Quartier et al. ANNALS OF THE RHEUMATIC DISEASES
- Is it time to move to active comparator trials in juvenile idiopathic arthritis?: A review of current study designs
- (2010) Nicolino Ruperto et al. ARTHRITIS AND RHEUMATISM
- The effect of genotype on methotrexate polyglutamate variability in juvenile idiopathic arthritis and association with drug response
- (2010) Mara L. Becker et al. ARTHRITIS AND RHEUMATISM
- Genome-wide association studies in pharmacogenomics
- (2010) Ann K. Daly NATURE REVIEWS GENETICS
- Guidelines for the Ethical Conduct of Studies to Evaluate Drugs in Pediatric Populations
- (2010) R. E. Shaddy et al. PEDIATRICS
- A pragmatic–explanatory continuum indicator summary (PRECIS): a tool to help trial designers
- (2009) Kevin E. Thorpe et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Development of a Large-Scale De-Identified DNA Biobank to Enable Personalized Medicine
- (2008) DM Roden et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Pediatric Antihypertensive Trial Failures
- (2008) Daniel K. Benjamin et al. HYPERTENSION
- Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial
- (2008) Nicolino Ruperto et al. LANCET
- Adalimumab with or without Methotrexate in Juvenile Rheumatoid Arthritis
- (2008) Daniel J. Lovell et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started